Skip to main content
. 2021 Aug 18;2021(8):CD014201. doi: 10.1002/14651858.CD014201

Morfini 1976.

Study characteristics
Methods RCT.
Cross‐over trial.
Trial period: 1 year.
Time unit: 3‐month cycles (A‐B‐A‐B versus B‐A‐B‐A).
Participants Country: Italy.
Participants: males with haemophilia B (factor IX < 1%).
Age range: 5 ‐ 45 years.
Number enrolled: 10.
Interventions Two secondary prophylaxis treatment arms.
Factor IX concentrate (Bebulin).
Arm A: 7.5 U/kg twice weekly.
Arm B: 15 U/kg weekly.
Follow‐up duration: 6 months per arm.
Outcomes Bleeding events or frequency, joint deterioration.
Notes Study involved participants of the Research Committee of the Fondazione dell’Emofilia.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk No information given.
Allocation concealment (selection bias) Low risk Quote: "Allocation to treatment protocols was made on the basis of random envelopes...".
Blinding (performance bias and detection bias)
Clinical Joint Function Low risk The personnel involved in the orthopedic examinations was blinded.
Blinding (performance bias and detection bias)
Bleeding High risk No blinding.
Blinding (performance bias and detection bias)
Radiologic Joint Score Low risk Radiological examinations were carried out in a blinded fashion.
Blinding of outcome assessment (detection bias)
Bleeding High risk Haematologists were aware of patients' treatment.
Blinding of outcome assessment (detection bias)
Clinical Joint Function Low risk Quote: "Orthopedic and radiological examinations were carried out by staff who were unaware of the trial details."
Blinding of outcome assessment (detection bias)
Radiologic Joint Score Low risk Quote: "Orthopedic and radiological examinations were carried out by staff who were unaware of the trial details."
Incomplete outcome data (attrition bias)
All outcomes Low risk No missing data for primary outcome and minimal missing data for secondary outcomes.
Selective reporting (reporting bias) Low risk Protocol was not available but all expected outcomes were reported.
Other bias Unclear risk Washout period between arms was not clear.